clinical trial · NCT05391022
Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies
Constellation Pharmaceuticals·phase1·completed·n = 35
Advanced MalignanciesSolid TumorHematological MalignancyPelabresib
brief summary
Phase 1 2-part study to evaluate the effect of food on pharmacokinetics of pelabresib (CPI-0610) and the effect of pelabresib on QTc in patients with advanced malignancies
started
Jul 20, 2021
primary completion
Mar 8, 2023
completion
Feb 29, 2024
last updated
Jul 28, 2025
official title
A Phase 1, 2-Part Study to Evaluate the Effect of Food on Pharmacokinetics of Pelabresib (CPI-0610) and the Effect of Pelabresib on QTc in Patients With Advanced Malignancies
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol